# Ramadan Fasting Outcomes in Patients With Secondary Adrenal Insufficiency Before and After the Treatment of Hypotension.

> **NCT06832566** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Hopital La Rabta** · enrollment: 20 (estimated)

## Conditions studied

- Secondary Adrenal Insufficiency
- Hypotension

## Interventions

- **DRUG:** Fludrocortisone 0.1 Milligrams (mg)

## Key facts

- **NCT ID:** NCT06832566
- **Lead sponsor:** Hopital La Rabta
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-15
- **Primary completion:** 2025-04-15
- **Final completion:** 2025-04-15
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06832566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06832566, "Ramadan Fasting Outcomes in Patients With Secondary Adrenal Insufficiency Before and After the Treatment of Hypotension.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06832566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*